+ Chinese + English

首页关于格然林 | 新闻中心 | 服务与产品 | 文献知识库 | 基础设施 | 企业文化与人才 | 联系我们 |

药物开发服务

产品与服务信息

Carbohydrate Derivatives

Nucleosides and Reagents

Super-chelating Agents & MRI Contrast Agents

Heterocyclic Compounds

Intermediate & Building Blocks

Formulation Products and Drugs substances

Flavoring, Additives and Agricultural Products

Fire Retardants

Metal complexes

Bio-reagents and conjugation reagents

0371-6711 0368

Nucleosides and Reagents

首页 > 服务与产品 > Nucleosides and Reagents > Fluoro-modified nucleosides

GL100571 POST:2013-06-02
GL100570 POST:2013-06-02
GL100569 POST:2013-06-02
GL100568 POST:2013-06-02
GL100567 POST:2013-06-02
GL100566 POST:2013-06-02
GL100565 POST:2013-06-02
GL100563 POST:2013-06-02
GL100421 POST:2013-06-02
GL100419 POST:2013-06-02
GL100472 POST:2013-05-31
GL100466 POST:2013-05-31
GL100433 POST:2013-05-31
GL100432 POST:2013-05-31
GL100431 POST:2013-05-31
GL100304 POST:2012-05-12
GL100303 POST:2012-05-12
GL100310 POST:2012-05-12
GL100186 POST:2012-05-12
GL100185 POST:2012-05-12
GL100184 POST:2012-05-12
GL100183 POST:2012-05-12
GL100182 POST:2012-05-12
GL100287 POST:2012-05-12
GL100244 POST:2012-05-12
GL100243 POST:2012-05-12
GL100225 POST:2012-05-12
GL100224 POST:2012-05-12
GL100223 POST:2012-05-12
GL100222 POST:2012-05-12
GL100221 POST:2012-05-12
GL100220 POST:2012-05-12

CurrentPage:2/3 [1] [2] [3]

: 关于格然林 | 新闻中心 | 服务与产品 | 文献知识库 | 基础设施 | 企业文化与人才 | 联系我们 |

© 1998 - 2022 Granlen Inc. 保留所有权利豫ICP备19022032号-1